GMDA gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 525 industry peers in the Biotechnology industry. Both the profitability and financial health of GMDA have multiple concerns. GMDA is valied quite expensively at the moment, while it does show a decent growth rate.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

GMDA had negative earnings in the past year.
In the past year GMDA has reported a negative cash flow from operations.
In the past 5 years GMDA always reported negative net income.
In the past 5 years GMDA always reported negative operating cash flow.

1.2 Ratios

GMDA's Return On Assets of -61.65% is on the low side compared to the rest of the industry. GMDA is outperformed by 60.48% of its industry peers.

		Industry Rank	Sector Rank
ROA	-61.65%
ROE	N/A
ROIC	N/A

ROA(3y)-61.87%

ROA(5y)-54.88%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Gross Margin of GMDA (18.53%) is better than 75.47% of its industry peers.
GMDA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	18.53%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

GMDA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for GMDA has been increased compared to 1 year ago.
GMDA has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of -8.53, we must say that GMDA is in the distress zone and has some risk of bankruptcy.
GMDA's Altman-Z score of -8.53 is on the low side compared to the rest of the industry. GMDA is outperformed by 74.45% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	-8.53

ROIC/WACCN/A

WACC5.78%

2.3 Liquidity

A Current Ratio of 2.16 indicates that GMDA has no problem at all paying its short term obligations.
The Current ratio of GMDA (2.16) is worse than 75.98% of its industry peers.
GMDA has a Quick Ratio of 2.09. This indicates that GMDA is financially healthy and has no problem in meeting its short term obligations.
GMDA has a Quick ratio of 2.09. This is in the lower half of the industry: GMDA underperforms 75.47% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	2.16
Quick Ratio	2.09

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

GMDA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 49.19%, which is quite impressive.

EPS 1Y (TTM)49.19%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%86.67%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 50.79% on average over the next years. This is a very strong growth
GMDA is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 182.44% yearly.

EPS Next Y9.37%

EPS Next 2Y50.84%

EPS Next 3Y51.21%

EPS Next 5Y50.79%

Revenue Next Year808.75%

Revenue Next 2Y935.67%

Revenue Next 3Y499.3%

Revenue Next 5Y182.44%

3.3 Evolution

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for GMDA. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for GMDA. No positive earnings are expected for the next year.